| Product Code: ETC6530137 | Publication Date: Sep 2024 | Updated Date: Dec 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The import shipments of lipid regulators to Brunei in 2024 continued to be dominated by Malaysia, Singapore, Ireland, USA, and Australia. The market concentration, as measured by the HHI, increased significantly from 2023 to 2024, indicating a very high level of concentration among the top exporting countries. Despite a negative compound annual growth rate of -12.13% from 2020 to 2024, the market showed a slight improvement with a growth rate of -5.61% from 2023 to 2024. Brunei reliance on these key exporting countries for lipid regulators highlights the importance of monitoring market trends and diversifying import sources.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Brunei Lipid Regulators Market Overview |
3.1 Brunei Country Macro Economic Indicators |
3.2 Brunei Lipid Regulators Market Revenues & Volume, 2021 & 2031F |
3.3 Brunei Lipid Regulators Market - Industry Life Cycle |
3.4 Brunei Lipid Regulators Market - Porter's Five Forces |
3.5 Brunei Lipid Regulators Market Revenues & Volume Share, By Type, 2021 & 2031F |
4 Brunei Lipid Regulators Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increase in prevalence of lifestyle diseases such as obesity and cardiovascular diseases in Brunei |
4.2.2 Growing awareness about the importance of managing cholesterol levels among the population |
4.2.3 Government initiatives to promote healthy lifestyle choices and preventive healthcare |
4.3 Market Restraints |
4.3.1 High cost associated with lipid-regulating medications |
4.3.2 Limited access to healthcare facilities in certain regions of Brunei |
4.3.3 Potential side effects and safety concerns associated with lipid regulators |
5 Brunei Lipid Regulators Market Trends |
6 Brunei Lipid Regulators Market, By Types |
6.1 Brunei Lipid Regulators Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Brunei Lipid Regulators Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Brunei Lipid Regulators Market Revenues & Volume, By Statins, 2021- 2031F |
6.1.4 Brunei Lipid Regulators Market Revenues & Volume, By Non-statins, 2021- 2031F |
7 Brunei Lipid Regulators Market Import-Export Trade Statistics |
7.1 Brunei Lipid Regulators Market Export to Major Countries |
7.2 Brunei Lipid Regulators Market Imports from Major Countries |
8 Brunei Lipid Regulators Market Key Performance Indicators |
8.1 Average cholesterol levels in the population |
8.2 Number of new cases diagnosed with hyperlipidemia annually |
8.3 Percentage of the population adhering to lipid-lowering therapy |
8.4 Rate of prescription of lipid regulators by healthcare providers |
8.5 Patient satisfaction with lipid-regulating medications |
9 Brunei Lipid Regulators Market - Opportunity Assessment |
9.1 Brunei Lipid Regulators Market Opportunity Assessment, By Type, 2021 & 2031F |
10 Brunei Lipid Regulators Market - Competitive Landscape |
10.1 Brunei Lipid Regulators Market Revenue Share, By Companies, 2024 |
10.2 Brunei Lipid Regulators Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |